HKSH to Host Inaugural Asia-Oceania Proton Therapy Conference

HKSH Medical Group is set to host the inaugural Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO) Conference in Hong Kong from **November 7 to 9, 2025**. This landmark event marks a significant step forward in the field of proton therapy, following the introduction of Hong Kong’s first proton therapy system by HKSH in 2023.

The three-day conference will take place at the **Hong Kong Convention and Exhibition Centre** and the HKSH Proton Therapy Centre, under the theme, “Advancing Particle Therapy with Greater Precision and Image-Guidance.” With support from the **Hong Kong Tourism Board**, **InvestHK**, and nearly 30 local and regional healthcare organizations, the event aims to showcase the latest advancements in proton therapy technology.

Participants will include over **400 attendees** from various backgrounds, such as academic researchers, clinical doctors, and medical physicists. The conference will feature seminars and expert lectures that highlight cutting-edge technologies, clinical data, and success stories in proton therapy, aiming to elevate medical standards and provide new hope to cancer patients.

Wyman Li, the Chief Operating Officer of HKSH Medical Group, expressed the organization’s commitment to advancing medical education and research. He stated, “Over the past two years, the HKSH Proton Therapy Centre has treated more than **500 patients**, accumulating invaluable experience in precision cancer care.” Li emphasized the importance of integrating clinical expertise with a global perspective during the conference.

The conference will also present notable keynote speakers, including Prof. Marco Durante, Director of the Biophysics Department at GSI Helmholtz Centre for Heavy Ion Research in Germany, and Prof. Tatsuya Ohno, Chairman of the Department of Radiation Oncology at Gunma University Heavy Ion Medical Center in Japan. Their participation underscores the conference’s focus on fostering collaboration and innovation in particle therapy.

As the Asia-Pacific region plays an increasingly vital role in the advancement of proton therapy, the PTCOG-AO Conference aims to discuss various topics ranging from clinical applications to technological breakthroughs. Attendees can expect to learn about recent developments in image-guided technology, which enhances the precision of treatment plans while minimizing side effects.

Dr. Simon Tang, Chairman of the PTCOG-AO 2025 Organising Committee, remarked, “HKSH is honoured to host Hong Kong’s first PTCOG-AO Conference, bringing together leading experts in the field of particle therapy.” He highlighted the conference’s potential to foster regional collaboration and improve treatment standards across the Asia-Pacific region.

In addition to expert lectures, the conference will feature exhibits from leading industry companies showcasing the latest in particle technology. This unique combination of academic and practical insights aims to create a comprehensive learning environment for all participants.

The HKSH Proton Therapy Centre, which has established itself as a leader in cancer treatment technology, continues to promote advancements in precision cancer care through ongoing education and training initiatives.

HKSH Medical Group, officially launched in September 2017, strives to enhance public health and advance medicine through coordinated clinical services, medical education, and research. With its dedication to providing high-quality holistic care, HKSH aims to remain at the forefront of medical innovation in Hong Kong and beyond.

As the PTCOG-AO Conference approaches, HKSH looks forward to facilitating a valuable exchange of knowledge among medical professionals, ultimately contributing to improved clinical outcomes for cancer treatment across the region. For more information about the conference, visit [PTCOG-AO Conference Website](https://www.ptcog-ao2025.hk/).